Garetosmab is a fully-human monoclonal antibody designed to bind and neutralize Activin A, a major promoter of HO in patients with FOP.

Researchers in Germany have uncovered a hidden receptor, GPR133, that plays a vital role in bone strength. By activating it with a new compound called AP503, they boosted bone density in mice and even ...

Regeneron Pharmaceuticals said on Wednesday its experimental treatment for a rare genetic disorder affecting soft tissue ...

In the realm of spinal fusion surgery, the quest for faster, safer, and more reliable bone formation has led to a molecular innovation that is reshaping the standard of care: P-15 Peptide. This ...

Demonstrated in rabbits, the 3-D printer might someday print bone grafts directly onto fractures, complete with antibiotics to ease healing.

Researchers from the University of Birmingham, U.K., have identified bioactive peptide sequences in the PEPITEM molecule, and ...

Sustained hypoxia affects orthodontic tooth movement (OTM) by altering osteoclast and osteoblast differentiation, report researchers from the Institute of Science Tokyo, Japan. Hypoxic conditions ...